Clinical benefit of nanoparticle albumin-bound-paclitaxel in recurrent/metastatic head and neck squamous cell carcinoma resistant to cremophor-based paclitaxel or docetaxelJessica Ley, Douglas R. Adkins, Peter Oppelt et al.|Medical Oncology|2017Cited by 16
Establishing an integrated approach to head and neck cancer treatment and prevention: The Robert Ebert and Greg Stubblefield Head and Neck Tumor Center ModelRyan S. Jackson, Sandra Dimitri, Karolina A. Plonowska‐Hirschfeld et al.|Oral Oncology|2025Cited by 1